Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
Status:
Completed
Trial end date:
2019-02-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the concentration of vedolizumab in breast milk of
lactating women with active ulcerative colitis (UC) or Crohn's disease (CD) who are receiving
vedolizumab therapeutically.